Monday, December 29, 2025
ADVT 
National

Meng decision, two Michaels not linked: WH

Darpan News Desk The Canadian Press, 27 Sep, 2021 12:38 PM
  • Meng decision, two Michaels not linked: WH

WASHINGTON - The White House is playing down the links between the release of Canadians Michael Spavor and Michael Kovrig and last week's decision to abandon the extradition of Meng Wanzhou.

Press secretary Jen Psaki says the U.S. Department of Justice is an independent agency and reached the decision to pursue a deferred prosecution agreement with the Huawei executive on its own.

Meng was allowed to return to China after a New York judge approved the agreement Friday, and Spavor and Kovrig were on their way back to Canada that same night.

Psaki says U.S. President Joe Biden urged China at every turn to release the two men, whose arrests were widely seen as retribution for Canada's arrest of Meng in December 2018.

But she says abandoning the Meng case should not be taken as evidence of a shifting foreign policy approach toward China.

Republicans, most notably Florida Sen. Marco Rubio, have criticized the agreement and want the White House to brief Congress on how it came about.

"It may feel foreign to them that the Department of Justice is independent, but it is independent under this administration," Psaki said.

"No one should read it as an impact on our substantive policy. This is a legal matter and a legal decision."

Psaki was unable to say whether Biden was aware that a deferred prosecution was in the works when he spoke with Chinese President Xi Jinping earlier this month.

"Our policy has not changed, our policy toward China," she said.

"We're going to continue to hold (China) to account for its unfair economic practices, its course of actions around the world, and its human rights abuses. And we will continue to do that in partnership with our allies around the world."

MORE National ARTICLES

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety
Police agencies throughout the Lower Mainland are aware of several conflicts involving numerous crime groups that have resulted in murders and attempted murders in recent weeks in public places. Police are expecting the violence to continue and escalate.

Public warning issued against interacting with 11 individuals who pose a significant risk to public safety

411 COVID19 cases for Tuesday

411 COVID19 cases for Tuesday
There are 4,890 active cases of COVID-19 in the province. A further 133,383 people who tested positive have recovered. There have been two new COVID-19 related deaths, for a total of 1,650 deaths in British Columbia.

411 COVID19 cases for Tuesday

Trudeau tamps down talk of reopening U.S. border

Trudeau tamps down talk of reopening U.S. border
Trudeau acknowledges that discussions about the border are ongoing, but he's tamping down any expectations that travel restrictions could be lifted soon.

Trudeau tamps down talk of reopening U.S. border

Environmentalists happy with energy agency report

Environmentalists happy with energy agency report
The report, released Tuesday, says there is a narrow but viable pathway for a global energy sector with net-zero greenhouse gas emissions by 2050.

Environmentalists happy with energy agency report

PM wants ceasefire in Israeli-Palestinian conflict

PM wants ceasefire in Israeli-Palestinian conflict
He says the violence needs to stop and Canada will work with the international community to de-escalate the situation "so that there is no more loss of civilian life."

PM wants ceasefire in Israeli-Palestinian conflict

Second dose choice likely for AstraZeneca: Tam

Second dose choice likely for AstraZeneca: Tam
Tam's comments Tuesday come hours after a small Spanish study on mixing and matching vaccines reported that giving a Pfizer-BioNTech for the second dose after AstraZeneca is safe and produced a stronger immune response than a second dose of AstraZeneca.

Second dose choice likely for AstraZeneca: Tam